Nalaganje...
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Immunotherapy has shifted the clinical paradigm of cancer management. However, despite promising initial progress, immunotherapeutic approaches to cancer still suffer from relatively low response rates and the possibility of severe side effects, likely due to the low inherent immunogenicity of tumor...
Shranjeno v:
| izdano v: | Adv Sci (Weinh) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709995/ https://ncbi.nlm.nih.gov/pubmed/33304763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002365 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|